Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia

NCT05435300 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT05435300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05435300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia
Lead sponsor
Centre for Addiction and Mental Health
Phase
Observational
Overall status
Active, not recruiting
Start date
September 17, 2021
Completion date
September 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective, schizophrenia